Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 24INDUSTRY 12NETWORK 3NIH 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Specimen Handling 47Magnetic Resonance Spectroscopy 38Cyclophosphamide 28Vincristine 22Radiation 19Dexamethasone 19Etoposide 18Cisplatin 18Carboplatin 17Biopsy 17Radiotherapy 16Doxorubicin 13Cytarabine 13daratumumab 12Leucovorin 12Methotrexate 11Gemcitabine 11X-Rays 10Standard of Care 10Platinum 10Docetaxel 10durvalumab 9Rituximab 9Radiotherapy, Intensity-Modulated 9Prednisone 9Practice Guidelines as Topic 9Calcium Dobesilate 91,2-diaminocyclohexaneplatinum II citrate 9merphos 8dexamethasone acetate 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Androgen Antagonists × 90 days × Clear all
NCT03419234 2026-06-03

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
223 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

NCT01368588 2026-05-08

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Active not recruiting
2,590 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

NCT06235697 2026-04-14

ASCENDE-SBRT

Canadian Cancer Trials Group

Phase 3 Recruiting
710 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡